{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:26:52Z","timestamp":1790072812642,"version":"4.0.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,11,24]],"date-time":"2011-11-24T00:00:00Z","timestamp":1322092800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00259-011-1993-8","type":"journal-article","created":{"date-parts":[[2011,11,24]],"date-time":"2011-11-24T09:44:19Z","timestamp":1322127859000},"page":"493-500","source":"Crossref","is-referenced-by-count":61,"title":["18F-FDG PET\/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation"],"prefix":"10.1007","volume":"39","author":[{"given":"Thorsten","family":"Derlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian R.","family":"Habermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wisotzki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Ayuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Wolschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Klutmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolaus","family":"Kr\u00f6ger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,11,24]]},"reference":[{"key":"1993_CR1","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0140-6736(04)15736-X","volume":"363","author":"B Sirohi","year":"2004","unstructured":"Sirohi B, Powles R. Multiple myeloma. Lancet 2004;363:875\u201387.","journal-title":"Lancet"},{"key":"1993_CR2","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM199706053362307","volume":"336","author":"R Bataille","year":"1997","unstructured":"Bataille R, Harousseau JL. Multiple myeloma. N Engl J Med 1997;336:1657\u201364.","journal-title":"N Engl J Med"},{"key":"1993_CR3","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1056\/NEJMoa032290","volume":"349","author":"M Attal","year":"2003","unstructured":"Attal M, Harousseau JL, Facon T, Guilhot F, Doyen C, Fuzibet JG, et al. Single versus double autologous stem-cell transplantation for multiple myeloma. N Engl J Med 2003;349:2495\u2013502.","journal-title":"N Engl J Med"},{"key":"1993_CR4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/j.1365-2141.2006.06271.x","volume":"135","author":"B Barlogie","year":"2006","unstructured":"Barlogie B, Tricot GJ, van Rhee F, Angtuaco E, Walker R, Epstein J, et al. Long-term outcome results of the first tandem autotransplant trial for multiple myeloma. Br J Haematol 2006;135:158\u201364.","journal-title":"Br J Haematol"},{"key":"1993_CR5","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1038\/sj.leu.2404775","volume":"21","author":"N Kr\u00f6ger","year":"2007","unstructured":"Kr\u00f6ger N. Mini-Midi-Maxi? How to harness the graft-versus-myeloma effect and target molecular remission after allogeneic stem cell transplantation. Leukemia 2007;21:1851\u20138.","journal-title":"Leukemia"},{"key":"1993_CR6","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1002\/cncr.25228","volume":"116","author":"A Shimoni","year":"2010","unstructured":"Shimoni A, Hardan I, Ayuk F, Schilling G, Atanackovic D, Zeller W, et al. Allogenic hematopoietic stem-cell transplantation with reduced-intensity conditioning in patients with refractory and recurrent multiple myeloma: long-term follow-up. Cancer 2010;116:3621\u201330.","journal-title":"Cancer"},{"key":"1993_CR7","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1038\/sj.leu.2404284","volume":"20","author":"BG Durie","year":"2006","unstructured":"Durie BG, Harousseau JL, Miguel JS, Blad\u00e9 J, Barlogie B, Anderson K, et al. International uniform response criteria for multiple myeloma. Leukemia 2006;20:1467\u201373.","journal-title":"Leukemia"},{"key":"1993_CR8","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1046\/j.1365-2141.1998.00930.x","volume":"102","author":"J Blad\u00e9","year":"1998","unstructured":"Blad\u00e9 J, Samson D, Reece D, Apperley J, Bj\u00f6rkstrand B, Gahrton G, et al. Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant. Br J Haematol 1998;102:1115\u201323.","journal-title":"Br J Haematol"},{"key":"1993_CR9","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2967\/jnumed.107.045641","volume":"49","author":"R Fonti","year":"2008","unstructured":"Fonti R, Salvatore B, Quarantelli M, Sirignano C, Segreto S, Petruzziello F, et al. 18F-FDG PET\/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma. J Nucl Med 2008;49:195\u2013200.","journal-title":"J Nucl Med"},{"key":"1993_CR10","first-page":"1457","volume":"43","author":"BG Durie","year":"2002","unstructured":"Durie BG, Waxman AD, D\u2019Agnolo A, Williams CM. Whole-body (18)F-FDG PET identifies high-risk myeloma. J Nucl Med 2002;43:1457\u201363.","journal-title":"J Nucl Med"},{"key":"1993_CR11","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00259-005-0004-3","volume":"33","author":"C Nanni","year":"2006","unstructured":"Nanni C, Zamagni E, Farsad M, Castellucci P, Tosi P, Cangini D, et al. Role of 18F-FDG PET\/CT in the assessment of bone involvement in newly diagnosed multiple myeloma: preliminary results. Eur J Nucl Med Mol Imaging 2006;33:525\u201331.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1993_CR12","first-page":"1208","volume":"38","author":"AM el-Shirbiny","year":"1997","unstructured":"el-Shirbiny AM, Yeung H, Imbriaco M, Michaeli J, Macapinlac H, Larson SM. Technetium-99m-MIBI versus fluorine-18-FDG in diffuse multiple myeloma. J Nucl Med 1997;38:1208\u201310.","journal-title":"J Nucl Med"},{"key":"1993_CR13","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1007\/s00259-011-1738-8","volume":"38","author":"R Haznedar","year":"2011","unstructured":"Haznedar R, Aki SZ, Akdemir OU, Ozkurt ZN, Ceneli O, Ya\u011fc\u0131 M, et al. Value of (18)F-fluorodeoxyglucose uptake in positron emission tomography\/computed tomography in predicting survival in multiple myeloma. Eur J Nucl Med Mol Imaging 2011;38:1046\u201353.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1993_CR14","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.V75.4.823.823","volume":"75","author":"BG Durie","year":"1990","unstructured":"Durie BG, Stock-Novack D, Salmon SE, Finley P, Beckord J, Crowley J, et al. Prognostic value of pretreatment serum beta 2 microglobulin in myeloma: a Southwest Oncology Group Study. Blood 1990;75:823\u201330.","journal-title":"Blood"},{"key":"1993_CR15","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.ejca.2005.11.037","volume":"42","author":"BG Durie","year":"2006","unstructured":"Durie BG. The role of anatomic and functional staging in myeloma: description of Durie\/Salmon plus staging system. Eur J Cancer 2006;42:1539\u201343.","journal-title":"Eur J Cancer"},{"key":"1993_CR16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S0037-1963(01)90020-4","volume":"38","author":"NS Callander","year":"2001","unstructured":"Callander NS, Roodman GD. Myeloma bone disease. Semin Hematol 2001;38:276\u201385.","journal-title":"Semin Hematol"},{"key":"1993_CR17","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1182\/blood-2008-06-155820","volume":"112","author":"C Kobe","year":"2008","unstructured":"Kobe C, Dietlein M, Franklin J, Markova J, Lohri A, Amthauer H, et al. Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma. Blood 2008;112:3989\u201394.","journal-title":"Blood"},{"key":"1993_CR18","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/sj.bjc.6600122","volume":"86","author":"C Bokemeyer","year":"2002","unstructured":"Bokemeyer C, Kollmannsberger C, Oechsle K, Dohmen BM, Pfannenberg A, Claussen CD, et al. Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET. Br J Cancer 2002;86:506\u201311.","journal-title":"Br J Cancer"},{"key":"1993_CR19","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/annonc\/mdn768","volume":"20","author":"J Markova","year":"2009","unstructured":"Markova J, Kobe C, Skopalova M, Klaskova K, Dedeckova K, Pl\u00fctschow A, et al. FDG-PET for assessment of early treatment response after four cycles of chemotherapy in patients with advanced-stage Hodgkin\u2019s lymphoma has a high negative predictive value. Ann Oncol 2009;20:1270\u201374.","journal-title":"Ann Oncol"},{"key":"1993_CR20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.2307\/2529310","volume":"33","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159\u201374.","journal-title":"Biometrics"},{"key":"1993_CR21","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.2214\/ajr.184.4.01841199","volume":"184","author":"MA Bredella","year":"2005","unstructured":"Bredella MA, Steinbach L, Caputo G, Segall G, Hawkins R. Value of FDG PET in the assessment of patients with multiple myeloma. AJR Am J Roentgenol 2005;184:1199\u2013204.","journal-title":"AJR Am J Roentgenol"},{"key":"1993_CR22","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s00256-002-0580-2","volume":"31","author":"H Jadvar","year":"2002","unstructured":"Jadvar H, Conti PS. Diagnostic utility of FDG PET in multiple myeloma. Skeletal Radiol 2002;31:690\u20134.","journal-title":"Skeletal Radiol"},{"key":"1993_CR23","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s00256-006-0127-z","volume":"35","author":"RJ Breyer 3rd","year":"2006","unstructured":"Breyer 3rd RJ, Mulligan ME, Smith SE, Line BR, Badros AZ. Comparison of imaging with FDG PET\/CT with other imaging modalities in myeloma. Skeletal Radiol 2006;35:632\u201340.","journal-title":"Skeletal Radiol"},{"key":"1993_CR24","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/leu.2009.89","volume":"23","author":"M Dimopoulos","year":"2009","unstructured":"Dimopoulos M, Terpos E, Comenzo RL, Tosi P, Beksac M, Sezer O, et al. International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple myeloma. Leukemia 2009;23:1545\u201356.","journal-title":"Leukemia"},{"key":"1993_CR25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00259-001-0711-3","volume":"29","author":"H Schirrmeister","year":"2002","unstructured":"Schirrmeister H, Bommer M, Buck AK, M\u00fcller S, Messer P, Bunjes D, et al. Initial results in the assessment of multiple myeloma using 18F-FDG PET. Eur J Nucl Med Mol Imaging 2002;29:361\u20136.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1993_CR26","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3324\/haematol.10554","volume":"92","author":"E Zamagni","year":"2007","unstructured":"Zamagni E, Nanni C, Patriarca F, Englaro E, Castellucci P, Geatti O, et al. A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma. Haematologica 2007;92:50\u20135.","journal-title":"Haematologica"},{"key":"1993_CR27","first-page":"513","volume":"22","author":"C Nanni","year":"2008","unstructured":"Nanni C, Rubello D, Zamagni E, Castellucci P, Ambrosini V, Montini G, et al. 18F-FDG PET\/CT in myeloma with presumed solitary plasmocytoma of bone. In Vivo 2008;22:513\u20137.","journal-title":"In Vivo"},{"key":"1993_CR28","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1200\/JCO.2008.19.7814","volume":"27","author":"C Furth","year":"2009","unstructured":"Furth C, Steffen IG, Amthauer H, Ruf J, Misch D, Sch\u00f6nberger S, et al. Early and late therapy response assessment with [18F]fluorodeoxyglucose positron emission tomography in pediatric Hodgkin\u2019s lymphoma: analysis of a prospective multicenter trial. J Clin Oncol 2009;27:4385\u201391.","journal-title":"J Clin Oncol"},{"key":"1993_CR29","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1600-0609.2004.00331.x","volume":"73","author":"G Damaj","year":"2004","unstructured":"Damaj G, Mohty M, Vey N, Dincan E, Bouabdallah R, Faucher C, et al. Features of extramedullary and extraosseous multiple myeloma: a report of 19 patients from a single center. Eur J Haematol 2004;73:402\u20136.","journal-title":"Eur J Haematol"},{"key":"1993_CR30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1148\/radiol.09090629","volume":"254","author":"C Lin","year":"2010","unstructured":"Lin C, Luciani A, Belhadj K, Deux JF, Kuhnowski F, Maatouk M, et al. Multiple myeloma treatment response assessment with whole-body dynamic contrast-enhanced MR imaging. Radiology 2010;254:521\u201331.","journal-title":"Radiology"},{"key":"1993_CR31","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1182\/blood-2009-03-213280","volume":"114","author":"TB Bartel","year":"2009","unstructured":"Bartel TB, Haessler J, Brown TL, Shaughnessy Jr JD, van Rhee F, Anaissie E, et al. F18-fluorodeoxyglucose positron emission tomography in the context of other imaging techniques and prognostic factors in multiple myeloma. Blood 2009;114:2068\u201376.","journal-title":"Blood"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-011-1993-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-011-1993-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-011-1993-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T23:44:09Z","timestamp":1593301449000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-011-1993-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,24]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["1993"],"URL":"https:\/\/doi.org\/10.1007\/s00259-011-1993-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,24]]}}}